key: cord-1046094-hvluk7am
authors: Wang, Lan; Chen, Fei; Bai, Lang; Yi, Qun; Peng, Yong
title: In situ pulmonary thrombosis in patients with COVID-19 pneumonia: different phenotypes may exist
date: 2020-10-23
journal: Thromb Res
DOI: 10.1016/j.thromres.2020.10.022
sha: 064efe28930da4ff839b6bad6aaeb8391f26f357
doc_id: 1046094
cord_uid: hvluk7am

• In situ pulmonary thrombosis may exist in COVID-19 pneumonia patients with the features of peripheral and less extensive distribution. • We observed some thrombi located just within the infected lungs' consolidation lesions, likely due to active local inflammation. • We also observed some thrombi located in non-consolidation areas, likely due to hypercoagulability caused by systemic inflammation. • We hypothesize different phenotypes of in situ thrombosis may exist and necessitate different intensity of anticoagulant therapy.

We read with great interest the recent article by L.F. van Dam et al. entitled "Clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism: A different phenotype of thrombotic disease?" [1] . They reported the pulmonary emboli in COVID-19 affected patients are more likely to be located in the peripheral lung segments and are less extensive compared to those in patients without COVID-19 pneumonia and theorized the existence of in situ pulmonary thrombosis in patients with COVID-19 pneumonia.

Several researchers have proposed this concept [2, 3] based on the reported absence of deep venous thrombosis (DVT) in the majority of patients with pulmonary embolism (PE), the higher incidence of PE but not DVT in patients with COVID-19 compared to those without COVID-19 [4] [5] [6] , and pathologic findings of thrombosis within the pulmonary arteries in the absence of DVT in autopsy studies [7] . However, the clinical and radiological characteristics of in situ pulmonary thrombosis have not been analyzed in patients in whom DVT has been excluded. 

The authors have no conflict of interest to declare 

Clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism: A different phenotype of thrombotic disease?

COVID-19 and thrombotic complications: Pulmonary thrombosis rather than embolism?

Thrombosis and COVID-19 pneumonia: the clot thickens!

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in

Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels

Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective